(Q35928285)

11 August 2017

1 reference

title

A comprehensive team approach to the management of patients with Prader-Willi syndrome (English)

1 reference

11 August 2017

Urs Eiholzer

1

1 reference

11 August 2017

Barbara Y Whitman

series ordinal

2

1 reference

11 August 2017

language of work or name

1 reference

1 September 2004

1 reference

Journal of Pediatric Endocrinology and Metabolism

11 August 2017

published in

1 reference

11 August 2017

volume

17

1 reference

11 August 2017

issue

9

1 reference

11 August 2017

page(s)

1153-1175

1 reference

Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Prevalence study of Prader-Willi syndrome in North Dakota

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

DNA methylation based testing of 450 patients suspected of having Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Reference values for height and weight in Prader-Willi syndrome based on 315 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Prader-Willi Syndrome after age 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Pubertal development in the Prader-Labhart-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Prader-Willi syndrome: causes of death in an international series of 27 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Linear growth response to exogenous growth hormone in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Sleep and breathing abnormalities in a case of Prader-Willi syndrome. The effects of acute continuous positive airway pressure treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

The use of fluoxetine in an adolescent with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Risperidone in treating behavioural disturbances of Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.9.1153

10.1515/JPEM.2004.17.9.1153

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference